or
forgot password

    • cancer clinical trials in santa maria, CA

    • Phase III Lucanix™ Vaccine Therapy in Advanced Non-small Cell Lung Cancer (NSCLC) Following Front-line Chemotherapy
    Central Coast Medical Oncology Corporation
    Santa Maria, California 93454
    Lung Neoplasm, Carcinoma Non-small Cell Lung Cancer Stage IIIA, Carcinoma Non-small Cell Lung Cancer Stage IIIB, Carcinoma Non-small Cell Lung Cancer Stage IV
    Bevacizumab Plus Capecitabine (Xeloda) in Patients With Untreated Metastatic Colorectal Cancer
    Central Coast Medical Oncology Corporation
    Santa Maria, California 93454
    Colorectal Cancer
    A Study Comparing Bevacizumab Therapy With or Without Erlotinib for First-Line Treatment of Non-Small Cell Lung Cancer (ATLAS)
    Central Coast Medical Oncology
    Santa Maria, California 93454
    Non-Small Cell Lung Cancer
    TAC Versus TC for Adjuvant Breast Cancer
    Central Coast Medical Oncology Corporation
    Santa Maria, California 93454
    Breast Cancer
    Study of Adding AMG 479 to First Line Chemotherapy in Patients With Optimally Debulked Epithelial Ovarian Cancer
    Central Coast Medical Oncology Corporation
    Santa Maria, California 93454
    Ovarian Neoplasms
    A Study of EZN-2208 Administered With or Without Cetuximab in Patients With Metastatic Colorectal Carcinoma
    Location# 052
    Santa Maria, California 93454
    Metastatic Colorectal Cancer
    Study to Assess the Effectiveness of RCHOP With or Without VELCADE in Previously Untreated Non-Germinal Center B-Cell-like Diffuse Large B-Cell Lymphoma Patients
    Central Coast Medical Oncology Corporation
    Santa Maria, California 93454
    Non-Germinal B-Cell-like (GCB) Diffuse Large B-cell Lymphoma (DLBCL)
    Everolimus in Treating Patients With Previously Treated Unresectable or Metastatic Esophageal Cancer or Stomach Cancer
    Central Coast Medical Oncology Corporation
    Santa Maria, California 93454
    Esophageal Cancer, Gastric Cancer
    Safety and Efficacy of TKI258 in Relapsed or Refractory Multiple Myeloma Patients, Who Are With or Without t(4;14) Chromosomal Translocation
    Central Coast Medical Oncology Corporation
    Santa Maria, California 93454
    Relapsed or Refractory Multiple Myeloma
    PARP Inhibition for Triple Negative Breast Cancer (ER-/PR-/HER2-)With BRCA1/2 Mutations
    Central Coast Medical Oncology Corporation
    Santa Maria, California 93454
    Breast Cancer
    Connect® MM- The Multiple Myeloma Disease Registry
    TORI - Central Coast Medical Oncology
    Santa Maria, California 93454
    Multiple Myeloma
    LUX-Breast 1: BIBW 2992 (Afatinib) in HER2-positive Metastatic Breast Cancer Patients After One Prior Herceptin Treatment
    1200.75.10102 Boehringer Ingelheim Investigational Site
    Santa Maria, California
    Breast Neoplasms
    A Safety and Efficacy Study of Farletuzumab in Subjects With Adenocarcinoma of the Lung
    Central Coast Medical Oncology
    Santa Maria, California 93454
    Adenocarcinoma of the Lung
    Dasatinib and Gemcitabine Hydrochloride or Gemcitabine Hydrochloride Alone in Treating Patients With Pancreatic Cancer Previously Treated With Surgery
    TORI SANTA MARIA (Central Coast Medical Oncology Corporation)
    Santa Maria, California 93454
    Acinar Cell Carcinoma of Pancreas, Duct Cell Adenocarcinoma of the Pancreas, Pancreatic Carcinoma Recurrent, Stage IA Pancreatic Cancer, Stage IB Pancreatic Cancer, Stage IIA Pancreatic Cancer, Stage IIB Pancreatic Cancer, Pancreatic Carcinoma Stage III
    Efficacy and Safety Study of CAL-101 in Patients With Indolent B-Cell Non-Hodgkin Lymphoma
    Central Coast Medical Oncology
    Santa Maria, California 93454
    Indolent Non-Hodgkin Lymphoma, Follicular Lymphoma, Small Lymphocytic Lymphoma, Lymphoplasmacytoid Lymphoma, Marginal Zone Lymphoma
    Study of Carfilzomib for Multiple Myeloma Patients Who Are Relapsed/Refractory to Bortezomib-containing Treatments
    Central Coast Medical Oncology
    Santa Maria, California 93454
    Multiple Myeloma
    A Phase II Study to Evaluate the Efficacy of TKI258 for the Treatment of Patients With FGFR2 Mutated or Wild-type Advanced and/or Metastatic Endometrial Cancer
    Central Coast Medical Oncology Corporation
    Santa Maria, California 93454
    Solid Tumors and Advanced Endometrial Cancer, Endometrial Cancer, Second-line Treatment, VEGF
    A Study of MM-121 With Paclitaxel in Platinum Resistant/ Refractory Advanced Ovarian Cancers
    Central Coast Medical Oncology
    Santa Maria, California 93454
    Epithelial Ovarian Cancer, Fallopian Tube Cancer, Peritoneal Cancer
    Efficacy and Safety of GS-6624 With FOLFIRI as Second Line Treatment in Colorectal Adenocarcinoma
    Central Coast Medical Oncology Corp
    Santa Maria, California
    Colorectal Cancer
    Morphotek Investigation in Colorectal Cancer: Research of MORAb-004 (MICRO)
    Central Coast Medical Oncology
    Santa Maria, California 93454
    Metastatic Colorectal Cancer, Colorectal Cancer
    Trial of Active Immunotherapy With Globo H-KLH (OPT-822) in Metastatic Breast Cancer Subjects
    Central Coast Medical Oncology Corporation
    Santa Maria, California 93454
    Metastatic Breast Cancer
    Open-label Extension Study of Navitoclax in Subjects With Chronic Lymphocytic Leukemia (CLL)
    Site Reference ID/Investigator# 74039
    Santa Maria, California 93454
    Chronic Lymphocytic Leukemia
    Treatment Extension Study for Patients Who Have Previously Participated and Have Benefited From Iniparib in a Clinical Trial
    Investigational Site Number 840033
    Santa Maria, California 93454-8903
    Solid Tumors
    Irinotecan in Treating Patients With Esophageal or Stomach Cancer
    Marian Medical Center
    Santa Maria, California 93454
    Esophageal Cancer, Gastric Cancer
    Study of AS1404 With Docetaxel in Patients With Hormone Refractory Metastatic Prostate Cancer
    Central Coast Medical Oncology Corporation
    Santa Maria, California 93454
    Prostate Cancer
    Treatment of Prostate Cancer With Adjuvant Bevacizumab Plus Erlotinib
    Central Coast Medical Oncology Corporation
    Santa Maria, California 93454
    Prostate Cancer
    Study of VELCADE and Rituximab in Patients With Relapsed or Refractory B-cell Non-Hodgkin's Lymphoma
    Central Coast Medical Oncology Corporation
    Santa Maria, California 93454
    Non-Hodgkin's Lymphoma
    Rheumatoid Arthritis: Comparison of Active Therapies in Patients With Active Disease Despite Methotrexate Therapy
    Pacific Arthritis Center (RAIN)
    Santa Maria, California 93454-6945
    Rheumatoid Arthritis
    Study of EC145 in Patients With Advanced Ovarian and Endometrial Cancers
    Central Coast Medical Oncology Corporation
    Santa Maria, California 93454
    Ovarian Cancer, Endometrial Cancer
    Study of EC145 in Patients With Progressive Adenocarcinoma of the Lung
    Central Coast Medical Oncology Corporation
    Santa Maria, California 93454
    Adenocarcinoma of the Lung
    Phase 2 Study Comparing Two Dose Schedules of Telintra™ in Myelodysplastic Syndrome (MDS)
    Central Coast Medical Oncology Corporation
    Santa Maria, California 93454
    Myelodysplastic Syndrome (MDS)
    Study of Telintra for Treatment of Chemotherapy Induced Neutropenia in Patients With Non‑Small Cell Lung Cancer
    Central Coast Medical Oncology Corporation
    Santa Maria, California 93454
    Non-small Cell Lung Cancer
    Safety and Efficacy of TKI258 in FGFR1 Amplified and Non-amplified Metastatic HER2 Negative Breast Cancer
    Central Coast Medical Oncology Corporation
    Santa Maria, California 93454
    Metastatic Breast Cancer
    Study of ACE-011 to Determine Safe and Effective Dose of ACE-011 for the Treatment of Chemotherapy Induced Anemia in Patients With Advanced Non-small Cell Lung Cancer
    Central Coast Medical Oncology Group
    Santa Maria, California 93454
    Anemia, Carcinoma, Non-Small-Cell Lung, Carcinoma, Small-Cell Lung, Bladder Cancer, Cancer of Head and Neck, Uterine Cervical Cancer